FDA Support for Conferences and Scientific Meetings (R13 Clinical Trial Not Allowed)
Last verified by NonDilute: 2026-06-08. Official notice and agency instructions control.
If you organize scientific meetings or conferences in regulatory science or FDA-relevant fields, this grant can cover direct costs—but you'll need institutional backing and clarity on the sparse eligibility rules.
Report stale or inaccurate summary
What this is
This is an R13 grant mechanism from the FDA designed to provide financial support for organizing and hosting conferences, workshops, and scientific meetings that align with FDA priorities in regulatory science, product evaluation, and public health. The funding explicitly excludes meetings centered on clinical trial design or execution. This opportunity is best suited for organizations capable of convening experts and stakeholders around FDA-relevant topics, though the source material provides minimal detail on budget ranges, eligibility criteria, or specific application requirements.
Who can apply
Eligible applicants typically include academic institutions, non-profit organizations, and established companies capable of hosting FDA-aligned conferences and scientific meetings. Clinical trial–focused meetings are explicitly ineligible. Detailed eligibility requirements are not provided in this source material and should be verified in the full RFP.
Topics: fda conference funding · scientific meetings grants · regulatory science · r13 grant mechanism · fda-supported conferences
Public-source funding discovery only. This summary is generated from public agency data and may be incomplete or stale. NonDilute is not affiliated with, endorsed by, or acting on behalf of any government agency. Official notices and agency instructions control. NonDilute does not determine eligibility, provide grant-writing advice, or guarantee funding.